Cutler Group’s Syneron Medical Ltd ELOS Stock Holding History

Cutler Group’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,000	Closed	-$7K	–	7796
2016 Q4	$7K	Buy	+12,000	New	+$94.1K	﹤0.01%	4689

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Cutler Group's ELOS Position: Q3 2017 in Review

Cutler Group sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 3,450 shares — an estimated $37K sold.

Cutler Group first reported a position in ELOS in Q4 2015 and held it in 7 quarters. The position peaked at $37K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

Cutler Group reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
Cutler Group sold 3,450 Syneron Medical Ltd shares in Q3 2017, an estimated $37K.
Cutler Group first reported a position in Syneron Medical Ltd in Q4 2015 and held it in 7 quarters.
Cutler Group's Syneron Medical Ltd position peaked at $37K in Q2 2017.
4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.